Related Experiment Video
Updated: Jan 12, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Characteristics of patients with heart failure and normal ejection fraction
Yusuke Funato1, Hideki Kawai1, Yuji Kono2
1Department of Cardiology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Insights
A low skeletal muscle index is a key characteristic of heart failure with normal ejection fraction (HFnEF). This finding suggests that increasing muscle mass through nutrition and exercise may improve outcomes for HFnEF patients unresponsive to medication.
Area of Science:
- Cardiology
- Geriatrics
- Internal Medicine
Background:
- A new classification divides heart failure into heart failure with normal ejection fraction (HFnEF) and non-HFnEF based on medication effects.
- The characteristics of HFnEF patients remain unclear, necessitating further investigation into associated factors.
Purpose of the Study:
- To identify the demographic and clinical characteristics, including non-cardiac factors, of patients diagnosed with HFnEF.
- To understand the background factors contributing to HFnEF.
Main Methods:
- Retrospective analysis of 304 hospitalized heart failure patients from December 2020 to December 2022.
- Patients were divided into HFnEF (n=37) and non-HFnEF (n=267) groups for comparison of characteristics.
- Multivariate analysis was performed, including patient sex, to identify independent determinants of HFnEF.
Main Results:
- The HFnEF group exhibited a higher proportion of patients with a low skeletal muscle index (<7.0 kg/m² for men, <5.7 kg/m² for women).
- Older age, low NT-proBNP levels, and a low skeletal muscle index were identified as independent determinants of HFnEF.
- The non-HFnEF group had more elderly patients, fewer with coronary artery disease, and lower serum hemoglobin levels.
Conclusions:
- A low skeletal muscle index is significantly more prevalent in HFnEF patients compared to non-HFnEF patients.
- Targeted nutrition and exercise interventions to enhance skeletal muscle mass could potentially improve prognosis in HFnEF patients.
- Further research into non-cardiac factors like skeletal muscle mass is crucial for managing HFnEF.
Objectives:
A new classification of heart failure based on the effects of medication has recently come into use. According to this classification, heart failure is divided into heart failure with normal ejection fraction (HFnEF; defined as an EF ≥55% for men and ≥60% for women) and non-HFnEF. However, the characteristics of patients with HFnEF are still unclear. Accordingly, in this study, we sought to identify the background characteristics, including non-cardiac factors, of patients with HFnEF.
Methods:
We retrospectively divided 304 eligible patients who were hospitalized for worsening heart failure at our institution between December 2020 and December 2022 into an HFnEF group (n=37) and a non-HFnEF group (n=267) and compared their demographic and clinical characteristics.
Results:
There were more elderly patients in the non-HFnEF group, along with fewer patients with coronary artery disease and low serum hemoglobin and NT-proBNP levels and a higher proportion of patients with a low skeletal muscle index (<7.0 kg/m2 for men and <5.7 kg/m2 for women). Multivariate analysis with addition of patient sex identified a low skeletal muscle index (odds ratio 2.96, p<0.01) to be an independent determinant of HFnEF along with older age and low NT-proBNP.
Conclusions:
A low skeletal muscle index was significantly more common in patients with HFnEF than in those with non-HFnEF. Intensive nutrition and exercise therapy to increase skeletal muscle mass may improve the prognosis in patients with HFnEF who respond poorly to standard pharmacological treatment.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure VII: Nursing Interventions
Heart Failure III: Clinical Manifestations

